Legis Daily

To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs.

USA116th CongressHR-107| House 
| Updated: 1/25/2019
Michael C. Burgess

Michael C. Burgess

Republican Representative

Texas

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This bill terminates certain limitations regarding drug rebates under Medicaid. Currently, the maximum rebate that drug manufacturers must pay under Medicaid for single-source and innovator multiple-source drugs is 100% of the average manufacturer price of the drug. The bill specifies that this limitation only applies to rebate periods that begin before January 1, 2020.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 115-6642
To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs.
Jan 3, 2019
Introduced in House
Jan 3, 2019
Referred to the House Committee on Energy and Commerce.
Jan 25, 2019
Referred to the Subcommittee on Health.

  • Bill from Previous Congress

    HR 115-6642
    To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs.
  • January 3, 2019
    Introduced in House
  • January 3, 2019
    Referred to the House Committee on Energy and Commerce.
  • January 25, 2019
    Referred to the Subcommittee on Health.

Health

Related Bills

  • HR 116-4996: Helping Medicaid Offer Maternity Services Act of 2020
Health care costs and insuranceMedicaidPrescription drugs

To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs.

USA116th CongressHR-107| House 
| Updated: 1/25/2019
This bill terminates certain limitations regarding drug rebates under Medicaid. Currently, the maximum rebate that drug manufacturers must pay under Medicaid for single-source and innovator multiple-source drugs is 100% of the average manufacturer price of the drug. The bill specifies that this limitation only applies to rebate periods that begin before January 1, 2020.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 115-6642
To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs.
Jan 3, 2019
Introduced in House
Jan 3, 2019
Referred to the House Committee on Energy and Commerce.
Jan 25, 2019
Referred to the Subcommittee on Health.

  • Bill from Previous Congress

    HR 115-6642
    To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs.
  • January 3, 2019
    Introduced in House
  • January 3, 2019
    Referred to the House Committee on Energy and Commerce.
  • January 25, 2019
    Referred to the Subcommittee on Health.
Michael C. Burgess

Michael C. Burgess

Republican Representative

Texas

Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • HR 116-4996: Helping Medicaid Offer Maternity Services Act of 2020
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Health care costs and insuranceMedicaidPrescription drugs